Gentian

Gentian root is the standard bitter tonic of European herbal medicine. It is given for poor appetite, indigestion, flatulence and bloating ^{39Reference 39European Medicines Agency · 2018ReviewAssessment report on Gentiana lutea L., radix, Revision 1 (EMA/HMPC/607863/2017) — regulatory review. https://www.ema.europa.eu/en/documents/herbal-report/assessment-report-gentiana-lutea-l-radix-revision-1_en.pdfView study →}.

It is taken before meals, as a tea, tincture or extract ^{38Reference 38European Medicines Agency · 2018ReviewEuropean Union herbal monograph on Gentiana lutea L., radix, Revision 1 (EMA/HMPC/607861/2017) — regulatory monograph. https://www.ema.europa.eu/en/documents/herbal-monograph/european-herbal-monograph-gentiana-lutea-l-radix-revision-1_en.pdfView study →}. The same root flavours regional aperitifs and liqueurs, especially in central Italy ^{6Reference 6Falcone G et al. · 2025Phytochemical profiling and anti-inflammatory activity of Gentiana lutea roots — ex vivoView study →}.

It is also used as a tonic for the liver and bile flow.

The leaves have a separate folk use: they were smoked for angina pectoris ^{35Reference 35Janković T et al. · 2025In vitroSmoking of Gentiana lutea leaves: validation of its traditional use — in vitroView study →}. The root has a little-known traditional use for respiratory complaints ^{7Reference 7Wildhaber J et al. · 2026In vitroSafety and anti-inflammatory activity of Gentiana lutea L. in human bronchial epithelial cells — in vitroView study →}.

This is gentian’s defining action. Amarogentin has a bitterness value of 58 million, which makes it the most bitter substance known. The more abundant gentiopicroside has a bitterness value of 12,000 ^{39Reference 39European Medicines Agency · 2018ReviewAssessment report on Gentiana lutea L., radix, Revision 1 (EMA/HMPC/607863/2017) — regulatory review. https://www.ema.europa.eu/en/documents/herbal-report/assessment-report-gentiana-lutea-l-radix-revision-1_en.pdfView study →}.

Bitter compounds stimulate the taste nerves in the mouth, which increases the secretion of gastric juice and bile. The European assessment also found evidence of a direct effect in the stomach, which supports taking gentian as a capsule or tablet ^{39Reference 39European Medicines Agency · 2018ReviewAssessment report on Gentiana lutea L., radix, Revision 1 (EMA/HMPC/607863/2017) — regulatory review. https://www.ema.europa.eu/en/documents/herbal-report/assessment-report-gentiana-lutea-l-radix-revision-1_en.pdfView study →}.

In animals, decoctions of four Siberian gentian species (not G. lutea) stimulated gastric acid, enzyme and mucus secretion ^{3Reference 3Olennikov DN et al. · 2015In vitroIridoids and flavonoids of four Siberian gentians: chemical profile and gastric stimulatory effect — animal/in vitroView study →}.

A Brazilian combination product of chamomile, fennel and gentian reduced cisplatin-induced vomiting and relaxed the duodenum in rodents, but it did not change gastric secretion volume or acidity ^{4Reference 4Silveira ES et al. · 2019AnimalGastrointestinal effects of a standardized Brazilian phytomedicine containing Gentiana lutea — animal modelView study →}.

In an open, uncontrolled study, 205 patients with indigestion took a dry gentian root extract (about 576 mg a day, equivalent to 2.9 g of root) for 15 days. Symptoms improved by an average of 68%, and doctors rated the result excellent or good in 86% of patients ^{39Reference 39European Medicines Agency · 2018ReviewAssessment report on Gentiana lutea L., radix, Revision 1 (EMA/HMPC/607863/2017) — regulatory review. https://www.ema.europa.eu/en/documents/herbal-report/assessment-report-gentiana-lutea-l-radix-revision-1_en.pdfView study →}.

Gap: no randomised controlled trial of gentian on its own for appetite loss or indigestion. The European Medicines Agency’s recognition rests on traditional use ^{38,39Reference 38European Medicines Agency · 2018ReviewEuropean Union herbal monograph on Gentiana lutea L., radix, Revision 1 (EMA/HMPC/607861/2017) — regulatory monograph. https://www.ema.europa.eu/en/documents/herbal-monograph/european-herbal-monograph-gentiana-lutea-l-radix-revision-1_en.pdfView study →Reference 39European Medicines Agency · 2018ReviewAssessment report on Gentiana lutea L., radix, Revision 1 (EMA/HMPC/607863/2017) — regulatory review. https://www.ema.europa.eu/en/documents/herbal-report/assessment-report-gentiana-lutea-l-radix-revision-1_en.pdfView study →}.

Anti-inflammatory activity appears in both whole-root extracts and the main constituent.

A hydroalcoholic root extract made to mimic traditional Italian gentian liqueur lowered IL-6 and TNF-α and raised IL-10 in inflamed mouse colon tissue ^{6Reference 6Falcone G et al. · 2025Phytochemical profiling and anti-inflammatory activity of Gentiana lutea roots — ex vivoView study →}.

An aqueous root extract lowered IL-6 and IL-8 in human Calu-3 bronchial epithelial cells without harming the cells ^{7Reference 7Wildhaber J et al. · 2026In vitroSafety and anti-inflammatory activity of Gentiana lutea L. in human bronchial epithelial cells — in vitroView study →}.

In mice with experimental osteoarthritis, a mixture of Prunella vulgaris and gentian extracts in an 8:2 ratio protected joint cartilage. Gentian extract on its own was tested only in cells, where it lowered COX-2 expression ^{8Reference 8Kim J et al. · 2022In vitroAnti-osteoarthritic effects of Prunella vulgaris and Gentiana lutea in vitro and in vivo — animal modelView study →}.

Gentiopicroside has been studied as a lead COX-2 inhibitor ^{13Reference 13Zhang QL et al. · 2022In vitroSynthesis and anti-inflammatory activities of gentiopicroside derivatives (COX-2) — in vitro/animalView study →}. It reduced arthritis severity in rats with adjuvant arthritis ^{11Reference 11Xie X et al. · 2019AnimalTherapeutic effects of gentiopicroside on adjuvant-induced arthritis in rats — animal modelView study →}, eased collagen-induced arthritis in mice through the CD147/p38/NF-κB pathway, using gentiopicroside from G. macrophylla ^{12Reference 12Jia N et al. · 2022AnimalGentiopicroside attenuates collagen-induced arthritis in mice via CD147/p38/NF-κB — animal modelView study →}, and reduced sepsis-induced lung injury in rats ^{14Reference 14Hu M et al. · 2024AnimalGentiopicroside ameliorates sepsis-induced acute lung injury — animal modelView study →}.

Gap: entirely preclinical. The strongest arthritis and lung data are for isolated gentiopicroside, at doses far above a bitters dose of the root.

Gentian is used traditionally as a liver tonic.

In rats with liver injury from carbon tetrachloride, three days of an ethanolic extract of G. lutea subsp. symphyandra root restored the reduced bile flow. A single dose had no effect ^{2Reference 2Öztürk N et al. · 1998AnimalCholeretic activity of Gentiana lutea ssp. symphyandra in rats — animal modelView study →}.

The stronger data are for gentiopicroside. Given orally to mice, it reduced liver enzymes, lipid peroxidation and TNF-α in D-galactosamine/LPS liver failure ^{15Reference 15Lian LH et al. · 2010AnimalAnti-apoptotic activity of gentiopicroside in D-galactosamine/LPS-induced murine fulminant hepatic failure — animal modelView study →}.

In diet-induced fatty liver disease in mice, it improved steatohepatitis and fibrosis by suppressing TLR4 and NLRP3 signalling ^{17Reference 17Yong Q et al. · 2024AnimalGentiopicroside improves NASH and liver fibrosis by suppressing TLR4 and NLRP3 — animal modelView study →}, reduced weight gain, liver enzymes and triglycerides while changing the gut microbiome ^{18Reference 18Wang L et al. · 2023AnimalGentiopicroside improves high-fat-diet NAFLD via serum metabolome and gut microbiome in mice — animal modelView study →}, and acted through PPARα and HIF-1α ^{19Reference 19Huang C et al. · 2024AnimalGentiopicroside improves non-alcoholic steatohepatitis by activating PPARα and suppressing HIF1 — animal modelView study →}. The last of these studies used gentiopicroside from Gentiana scabra ^{19Reference 19Huang C et al. · 2024AnimalGentiopicroside improves non-alcoholic steatohepatitis by activating PPARα and suppressing HIF1 — animal modelView study →}.

In rats, the oral bioavailability of gentiopicroside was about 10% ^{16Reference 16Chang-Liao WL et al. · 2012AnimalGentiopicroside from Gentianae Radix and its pharmacokinetics in liver ischemia/reperfusion rats — animal modelView study →}.

Gap: no human liver data. The fatty-liver and fibrosis results are for isolated gentiopicroside.

The root extract scavenges free radicals in DPPH and TEAC assays and slowed lipid oxidation in an oil-in-water emulsion ^{20Reference 20Azman NA et al. · 2014In vitroScreening of antioxidant activity of Gentiana lutea root in oil-in-water emulsions — in vitroView study →}. Extracts also inhibited myeloperoxidase, an enzyme behind neutrophil-driven oxidative damage; among the isolated constituents, gentiopicroside was the strongest inhibitor ^{21Reference 21Nastasijević B et al. · 2012In vitroInhibition of myeloperoxidase and antioxidative activity of Gentiana lutea extracts — in vitroView study →}.

G. lutea extracts also protect DNA. Root and leaf extracts reduced DNA damage from cooked-meat mutagens in HepG2 cells while supporting Nrf2 and glutathione ^{22Reference 22Cvetković S et al. · 2020In vitroAntigenotoxic activity of Gentiana lutea extracts against food-borne mutagens — in vitroView study →}. Extracts of laboratory-grown root and shoot limited UV-induced DNA damage ^{23Reference 23Cvetković S et al. · 2023In vitroThe role of Gentiana lutea extracts in reducing UV-induced DNA damage — in vitroView study →}.

Root extract also protected human blood mononuclear cells against gamma radiation ^{24Reference 24Kostić M et al. · 2026In vitroGentiana lutea root extract attenuates radiation-induced damage in human PBMCs — in vitroView study →} and against the chemotherapy drug hydroxyurea ^{25Reference 25Radošević K et al. · 2025In vitroGentiana lutea root aqueous extract mitigates hydroxyurea-induced genotoxicity in human PBMCs — in vitroView study →}.

All of this work is in vitro or in isolated human cells. None measured antioxidant effects after gentian was taken by mouth.

A G. lutea extract suppressed fat-cell formation in 3T3-L1 cells. In mice on a high-fat diet, 100 or 200 mg/kg a day for 12 weeks prevented weight gain and fatty liver ^{27Reference 27Park E et al. · 2020AnimalAntiobesity effects of Gentiana lutea extract on 3T3-L1 preadipocytes and high-fat-diet mice — animal modelView study →}.

Root extracts inhibited aldose reductase, the enzyme behind several diabetic complications, and reduced sorbitol build-up in human red blood cells in high glucose. Docking studies point to amarogentin as a likely inhibitor ^{28Reference 28Akileshwari C et al. · 2012In vitroInhibition of aldose reductase by Gentiana lutea extracts — in vitroView study →}.

In diabetic rats, a diet with 2% gentian root powder lowered blood cholesterol and reduced fat deposits and thickening in the aortic wall ^{9Reference 9Kesavan R et al. · 2016AnimalGentiana lutea prevents endothelial inflammation and smooth-muscle migration in diabetic rats — animal modelView study →}.

Two reviews collect the obesity, diabetes and vascular findings ^{26,29Reference 26Joksić G et al. · 2019ReviewPotential of Gentiana lutea for the treatment of obesity-associated diseases — reviewView study →Reference 29Joksić G et al. · 2021ReviewEffects of Gentiana lutea root on vascular diseases — reviewView study →}.

Gap: animal and cell studies only. No human trial has tested gentian for weight or blood sugar.

In a 2024 study, 50% hydroethanolic G. lutea root extracts relaxed isolated rat ileum and reduced both spontaneous and drug-induced contractions ^{5Reference 5Kitić N et al. · 2024AnimalSpasmolytic activity of Gentiana lutea L. root extracts on rat ileum — animal/ex vivoView study →}.

The effect ran mainly through several types of potassium channel, including calcium-activated, ATP-sensitive and voltage-sensitive channels, together with effects on calcium channels ^{5Reference 5Kitić N et al. · 2024AnimalSpasmolytic activity of Gentiana lutea L. root extracts on rat ileum — animal/ex vivoView study →}.

Gap: a single study on isolated rat tissue, with no whole-animal or human confirmation.

Applied to the skin, gentian works through a different route from the digestive bitter. G. lutea extract increased lipid synthesis in human keratinocytes, and amarogentin binds the keratinocyte bitter receptors TAS2R1 and TAS2R38 ^{30Reference 30Wölfle U et al. · 2017In vitroThe herbal bitter drug Gentiana lutea modulates lipid synthesis in human keratinocytes in vitro and in vivoView study →}. The extract also raised ceramide synthase 3 expression, including in psoriasis-like keratinocytes ^{31Reference 31Gendrisch F et al. · 2020In vitroGentiana lutea extract modulates ceramide synthesis in primary and psoriasis-like keratinocytes — in vitroView study →}.

In a half-side comparison on the forearms of 33 volunteers, gentian extract increased skin lipid content compared with placebo ^{30Reference 30Wölfle U et al. · 2017In vitroThe herbal bitter drug Gentiana lutea modulates lipid synthesis in human keratinocytes in vitro and in vivoView study →}.

In 22 people, a cream with a gentiopicroside-rich extract (65% gentiopicroside) applied around the eyes twice daily for 14 days reduced upper-eyelid roughness and the redness of dark circles compared with placebo ^{32Reference 32Berthon JY et al. · 2023In vitroIn vitro, ex vivo and clinical approaches to evaluate the effect of Gentiana lutea extract on skin — clinicalView study →}.

Gap: two small, short topical studies, neither independently replicated.

Methanolic extracts of G. lutea flowers and leaves, and the isolated compounds mangiferin, isogentisin and gentiopicroside, inhibited a range of Gram-positive and Gram-negative bacteria and Candida albicans, with MIC values of 0.12–0.31 mg/mL. The authors attributed the effect to synergy among the compounds ^{33Reference 33Šavikin K et al. · 2009In vitroAntimicrobial activity of Gentiana lutea L. extracts — in vitroView study →}.

The tested material was flower and leaf, not root.

Gap: a single in-vitro study, with no animal or clinical data.

Side effects. In the 205-patient open study, 2.4% of patients reported an adverse event: flatulence, soft stools, stomach cramps, nausea and headache, each in a single patient ^{39Reference 39European Medicines Agency · 2018ReviewAssessment report on Gentiana lutea L., radix, Revision 1 (EMA/HMPC/607863/2017) — regulatory review. https://www.ema.europa.eu/en/documents/herbal-report/assessment-report-gentiana-lutea-l-radix-revision-1_en.pdfView study →}. The 2009 European monograph listed headache as a possible side effect ^{40Reference 40European Medicines Agency · 2009ReviewCommunity herbal monograph on Gentiana lutea L., radix, first version (EMEA/HMPC/578324/2008) — regulatory monograph (superseded). https://www.ema.europa.eu/en/documents/herbal-monograph/superseded-community-herbal-monograph-gentiana-lutea-l-radix-first-version_en.pdfView study →}.

Stomach acid and bile. Gentian works by raising gastric acid and bile secretion. The 2009 European monograph listed peptic ulcer as a contraindication ^{40Reference 40European Medicines Agency · 2009ReviewCommunity herbal monograph on Gentiana lutea L., radix, first version (EMEA/HMPC/578324/2008) — regulatory monograph (superseded). https://www.ema.europa.eu/en/documents/herbal-monograph/superseded-community-herbal-monograph-gentiana-lutea-l-radix-first-version_en.pdfView study →}, and gentian is usually avoided with reflux or hyperacidity and with gallstones or a blocked bile duct. The 2018 revision lists only hypersensitivity to gentian root ^{38Reference 38European Medicines Agency · 2018ReviewEuropean Union herbal monograph on Gentiana lutea L., radix, Revision 1 (EMA/HMPC/607861/2017) — regulatory monograph. https://www.ema.europa.eu/en/documents/herbal-monograph/european-herbal-monograph-gentiana-lutea-l-radix-revision-1_en.pdfView study →}.

Lookalike. White hellebore (Veratrum album) grows in the same mountain pastures and has caused most of the poisonings recorded under gentian. Its leaves are alternate, while gentian’s grow in opposite pairs ^{39Reference 39European Medicines Agency · 2018ReviewAssessment report on Gentiana lutea L., radix, Revision 1 (EMA/HMPC/607863/2017) — regulatory review. https://www.ema.europa.eu/en/documents/herbal-report/assessment-report-gentiana-lutea-l-radix-revision-1_en.pdfView study →}.

Genotoxicity. Reproductive, genotoxicity and carcinogenicity tests have not been done on gentian root, and some of its xanthones tested positive in the Ames test ^{38Reference 38European Medicines Agency · 2018ReviewEuropean Union herbal monograph on Gentiana lutea L., radix, Revision 1 (EMA/HMPC/607861/2017) — regulatory monograph. https://www.ema.europa.eu/en/documents/herbal-monograph/european-herbal-monograph-gentiana-lutea-l-radix-revision-1_en.pdfView study →}. Assessing gentian tincture as an animal-feed additive, EFSA found no concern for consumers or short-lived animals, but it could not conclude on long-lived and breeding animals because of the in-vitro genotoxicity of xanthones and gentiopicroside ^{36Reference 36EFSA Panel (FEEDAP) · 2023ReviewSafety of a feed additive consisting of a tincture from the roots of Gentiana lutea — reviewView study →}.

Interactions. None have been reported ^{38Reference 38European Medicines Agency · 2018ReviewEuropean Union herbal monograph on Gentiana lutea L., radix, Revision 1 (EMA/HMPC/607861/2017) — regulatory monograph. https://www.ema.europa.eu/en/documents/herbal-monograph/european-herbal-monograph-gentiana-lutea-l-radix-revision-1_en.pdfView study →}. Because gentian raises stomach acid, it would in principle work against acid-suppressing medicines, though no such interaction has been measured.

Drug metabolism. In laboratory tests, gentiopicroside inhibited CYP2A6 but not CYP1A2, CYP2C9, CYP2D6 or CYP3A4, and did not induce drug-metabolising enzymes in human liver cells ^{43Reference 43Deng Y et al. · 2013In vitroIn vitro inhibition and induction of human liver cytochrome P450 enzymes by gentiopicroside: potent effect on CYP2A6 — in vitroView study →}. In a liver cell line, amarogentin raised CYP3A4 expression ^{44Reference 44Dai K et al. · 2018In vitroHepatoprotective activity of iridoids, seco-iridoids and analog glycosides from Gentianaceae on HepG2 cells via CYP3A4 induction and mitochondrial pathway — in vitroView study →}. Neither finding has been tested in animals or people.

Children. Use under 18 is not recommended, for lack of data ^{38Reference 38European Medicines Agency · 2018ReviewEuropean Union herbal monograph on Gentiana lutea L., radix, Revision 1 (EMA/HMPC/607861/2017) — regulatory monograph. https://www.ema.europa.eu/en/documents/herbal-monograph/european-herbal-monograph-gentiana-lutea-l-radix-revision-1_en.pdfView study →}.